R adiofrequency A blation of P ulmonary TU mors R esponse E valuation ( RAPTURE) Trial Riccardo Lencioni, MD, Pisa, Italy Lencioni et al. Lancet Oncol 2008; 9:621-628. NSCLC (n = 33) CRC (n = 53) Other (n = 20) Total (n = 106) Gender (F :...